Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. - Hsu J; Hodgins JJ; Marathe M; Nicolai CJ; Bourgeois-Daigneault MC; Trevino TN; Azimi CS; Scheer AK; Randolph HE; Thompson TW; Zhang L; Iannello A; et al. (The Journal of clinical investigation, 2018)